Skip to main content

Daniel S. Farb

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Daniel S. Farb

Daniel S. Farb was last confirmed as Board Member at PharmaCyte Biotech, Inc. (PMCB) in a filing dated November 25, 2022. PharmaCyte Biotech, Inc. reported in an 8-K filed August 16, 2022 that Daniel S. Farb was appointed independent director. PharmaCyte Biotech, Inc. reported in an 8-K filed August 16, 2022 that Daniel S. Farb was appointed independent member of the Board, effective August 15, 2022.

“Jack E. Stover, Daniel S. Farb, and Daniel C. Allen will also join PharmaCyte's reconstituted Board as independent directors.”
PharmaCyte Biotech, Inc. Form 8-K, filed August 16, 2022 · Read the filing
“effective August 15, 2022, the Board appointed each of Messrs. Schechter, Silverman, Allen, Farb and Stover as independent members of the Board.”
PharmaCyte Biotech, Inc. Form 8-K, filed August 16, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.